Abbott | ABT - Resultado Líquido





Resultado Líquido Alterar Data
Abbott USD 920M 8M 2026-09
Agilent USD 362M 23M 2026-06
AtriCure USD 8.96M 8.85M 2026-06
Baxter International USD 126M 141M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Boston Scientific USD 907M 434M 2026-06
Cooper Companies USD 432.8M 510.7M 2026-06
Danaher USD 1.24B 365M 2026-09
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 14.85M 10.37M 2026-09
Intuitive Surgical USD 522.8M 295.3M 2026-09
J&J USD 210M 5.32B 2026-09
Medtronic USD 1.47B 227M 2026-06
Merit Medical Systems USD 38.8M 2.19M 2026-06
Pfizer USD -248M 2.94B 2026-06
Smith & Nephew USD 303M 10M 2026-06
Solventum Corp USD 92M 79M 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teleflex USD 99.69M 107.85M 2026-06
Terumo JPY 70.43B 44.06B 2026-06
Thermo Fisher Scientific USD 1.72B 15M 2026-09
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06